Arrowhead Pharmaceuticals
ARWR
#2187
Rank
HK$69.93 B
Marketcap
HK$499.42
Share price
-2.07%
Change (1 day)
421.82%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): HK$2.67 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are HK$1.09 Billion. , an increase over its 2024 earnings that were of -HK$4.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 HK$2.70 B-157.5%
2024 -HK$4.7 Billion112.45%
2023 -HK$2.22 Billion87.79%
2022 -HK$1.18 Billion-20.1%
2021 -HK$1.48 Billion67.59%
2020 -HK$0.88 Billion-347.53%
2019 HK$0.35 B-245.59%
2018 -HK$0.25 Billion-13.17%
2017 -HK$0.29 Billion-52.28%
2016 -HK$0.59 Billion-16.57%
2015 -HK$0.71 Billion30.32%
2014 -HK$0.55 Billion171.62%
2013 -HK$0.2 Billion16.56%
2012 -HK$0.18 Billion107.53%
2011 -HK$82.47 Million
2008 -HK$0.3 Billion-8.07%
2007 -HK$0.32 Billion70.37%
2006 -HK$0.19 Billion122.51%
2005 -HK$83.36 Million147.41%
2004 -HK$33.7 Million2002.28%
2003 -HK$1.61 Million-85.61%
2002 -HK$11.14 Million1371.97%
2001 -HK$0.76 Million-13.45%
2000 -HK$0.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.68 B 9,621.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$21.6 Billion-899.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$1.28 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.93 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$4.50 B 66.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$0.85 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA